The European Union on Wednesday approved mega deals involving drug makers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.
http://ift.tt/1Dhoh6R
3Novices Europe
http://ift.tt/1Dhoh6R
3Novices Europe
No comments:
Post a Comment